Related Experiment Video
Updated: Dec 11, 2025

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Risk Factors for Progression of Distal Deep Vein Thrombosis
Shunichiro Fujioka1, Hirotoki Ohkubo1, Tadashi Kitamura1
1Department of Cardiovascular Surgery, Kitasato University School of Medicine.
Insights
Conservative treatment may be suitable for distal deep vein thrombosis (DVT). Anticoagulation is recommended for patients with active cancer, prolonged bed rest, or high D-dimer levels to prevent clot extension.
Area of Science:
- Vascular Medicine
- Thrombosis Research
Background:
- Optimal treatment for distal deep vein thrombosis (DVT) remains unclear.
- Indications for anticoagulation therapy in distal DVT require further clarification.
Purpose of the Study:
- Evaluate treatment outcomes for distal DVT patients.
- Identify risk factors for DVT extension to proximal veins.
- Determine appropriate indications for anticoagulation therapy.
Main Methods:
- Retrospective analysis of 212 distal DVT patients treated conservatively with compression stockings.
- Initial treatment without immediate anticoagulation.
- Follow-up ultrasonography at 2 weeks and 3 months.
Main Results:
- Thrombus disappearance occurred in 52% of patients after 3 months.
- DVT extension to proximal veins occurred in 6.3% of patients.
- Risk factors for extension included active cancer, prolonged bed rest, and D-dimer >8µg/mL.
Conclusions:
- Conservative management is a viable option for select distal DVT patients.
- Anticoagulation therapy should be considered for distal DVT patients with active cancer, prolonged bed rest, or elevated D-dimer levels.
Background:
There is insufficient evidence regarding the optimal treatment method for distal deep vein thrombosis (DVT), including indications for anticoagulation therapy. Treatment results of patients with distal DVT were evaluated to clarify the risk factors that result in extension of distal DVT to the proximal vein and indications for anticoagulation therapy.
Methods And Results:
Among 430 patients with DVT between January 2018 and December 2019, 253 were diagnosed with distal DVT; 41 patients who had already started anticoagulation therapy were excluded, and the remaining 212 were included as study subjects. Anticoagulation therapy was not started immediately; conservative treatment with compression stockings was performed. Ultrasonography after 2 weeks revealed thrombus disappearance in 39 patients (21%), and thrombus reduction in 38 patients (20%). In contrast, extension of thrombus to the proximal vein was noted in 12 patients (6.3%) and anticoagulation therapy was commenced. After 3 months, the thrombus had disappeared in 75 patients (52%). No patient developed pulmonary thromboembolism during follow-up. With respect to the risk factors for extension to proximal vein during conservative treatment, active cancer (P=0.03), prolonged bed rest (P<0.01), and D-dimer level >8µg/mL (P=0.01) were identified.
Conclusions:
It is reasonable to consider anticoagulation therapy in distal DVT patients with active cancer, prolonged bed rest or high D-dimer level.
More Related Videos
Related Concept Videos
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis III: Interprofessional Care
Varicose Veins I: Introduction
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management

